Heart toxicity effects (HTE) of anthracyclines-containing regimens (ACRs) in patients with breast cancer (BC) carrying mutational signature of homologous recombination deficiency (HRD).

Authors

Lorena Incorvaia

Lorena Incorvaia

Dept.of Surgical,Oncological and Oral Sciences,Section of Medical Oncology,University of Palermo,Italy, Palermo, Italy

Lorena Incorvaia , Alessia Fiorino , Anna Paola Carreca , Stefania Gori , Saverio Cinieri , Giuseppe Curigliano , Chiara Brando , Marta Peri , Laura Orlando , Tancredi Didier Bazan Russo , Valerio Gristina , Erika Pedone , Marco Bono , Antonio Galvano , Valentina Calò , Giuseppina Novo , Giuseppe Badalamenti , Viviana Bazan , Ignazio Ugo Carreca , Antonio Russo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Prevention, Risk Reduction, and Hereditary Cancer

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Germline Genetic Testing

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 10519)

DOI

10.1200/JCO.2022.40.16_suppl.10519

Abstract #

10519

Poster Bd #

398

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting

The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?

The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?

First Author: Muhammad Danyal Ahsan

First Author: Nicole Casasanta

First Author: Jonathan Poh